Earn £3540 for COPD Study 224025

Website PAREXEL International Ltd.

uk clinical trials, clinical research uk

Trial Details for COPD Study 224025
Description This study drug is being developed for the treatment of Chronic Obstructive Pulmonary Disease (COPD). COPD is a disease of the airways that causes inflammation and narrowing of the airways making it difficult to breathe.
Qualifiers Health Status: Healthy
Gender: Both
Ages: 18 to 55
BMI Range: 18 to 30
Inconvenience Allowance Max Allowance: £3540
Screening Allowance: £0

To apply for this job please visit the following URL: https://www.drugtrial.co.uk/en/trial-listings/trial-details?trial_id=229 →